Newer Drugs Not Cost-Effective for First-Line Diabetes Therapy ...Middle East

Costs of SGLT2 inhibitors and GLP-1 receptor agonists 'need to be lowered substantially' to improve health outcomes and prevent health disparities in patients with type 2 diabetes, say researchers. Medscape Medical News

Hence then, the article about newer drugs not cost effective for first line diabetes therapy was published today ( Tuesday 04/10/2022 - 05:04 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Newer Drugs Not Cost-Effective for First-Line Diabetes Therapy )

Also on site :

• Human heads displayed at Ecuador tourist beach in warning to gangs
• Nazi salutes and drug cartels: Dutch mercenary recounts service with Kiev’s military
• Macy’s Valley Fair shoppers thwart Rolex watch thieves